A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2)

Abstract Background The objectives of this study were to build upon previously-reported 12-month findings by retrospectively comparing 24-month follow-up hospitalization charges and potentially-relevant readmissions in US lumbar fusion surgeries that employed either recombinant human bone morphogene...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bradley Wetzell, Julie B. McLean, Kimberly Dorsch, Mark A. Moore
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
CBA
Acceso en línea:https://doaj.org/article/d826b565be034d27911084479b6ada76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!